ZILVERPASS Study: ZILVER PTX Stent vs. Bypass Surgery in Femoropopliteal Lesions, 3 year results and economic analysis.

Marc Bosiers,Gianmarco DE Donato,Giovanni Torsello,Pierre Galvagni Silveira,Koen Deloose,Dierk Scheinert,Pierfrancesco Veroux,Jeroen Hendriks,Lieven Maene,Koen Keirse,Tulio Navarro,Joren Callaert,Hans-Henning Eckstein,Jörg Teβarek,Alessia Giaquinta,Wouter van den Eynde,Jürgen Verbist, Jasmin Ahl-Gravsen

The Journal of cardiovascular surgery（2023）

引用 1|浏览15

暂无评分

摘要

The non-inferior safety and effectiveness results of the ZILVER PTX stent were associated with lower costs for the payer and confirmed that ZILVER PTX stent treatment can be considered as a valid alternative for bypass surgery in long and complex femoropopliteal lesions.

查看译文

关键词

Drug-eluting stents, Endovascular procedures, Peripheral artery disease, Costs and cost analysis

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要